Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Guangdong Association of Clinical Trials
Novartis
Novartis
Pfizer
AstraZeneca
Shanghai Pulmonary Hospital, Shanghai, China
Institut Paoli-Calmettes
Fujian Cancer Hospital
Pfizer
Groupe Francais De Pneumo-Cancerologie
AstraZeneca
Merck Sharp & Dohme LLC
Amsterdam UMC, location VUmc
Hoffmann-La Roche
AstraZeneca
Radboud University Medical Center
Samsung Medical Center
Shanghai Chest Hospital
Maastricht University Medical Center
University Medical Center Groningen
West China Hospital
Radboud University Medical Center
The Affiliated Hospital of Qingdao University
Pfizer
Samsung Medical Center
Genentech, Inc.
Hangzhou Normal University
AstraZeneca
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chonnam National University Hospital
Radboud University Medical Center
Radboud University Medical Center
People's Hospital of Quzhou
University of Crete
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Peking University First Hospital
AstraZeneca
Centre Georges Francois Leclerc
Bristol-Myers Squibb
Henan Cancer Hospital
Boehringer Ingelheim
Hikma Pharmaceuticals LLC
Catalysis SL
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Peking University First Hospital
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Boehringer Ingelheim
Celgene
Shandong Cancer Hospital and Institute
University of Kansas Medical Center